MedPath

The use of metformin in patients with polycystic ovarian syndrome requiring treatment with in vitro fertilisation (IVF)

Not Applicable
Completed
Conditions
rological and Genital Diseases: Polycystic ovarian syndrome (PCOS)
Urological and Genital Diseases
Polycystic ovarian syndrome (PCOS)
Registration Number
ISRCTN47219228
Lead Sponsor
Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
100
Inclusion Criteria

Patients with PCOS

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Total number of folicles reaching 18 mm<br>2. Number of eggs obtained, number and quality of mature eggs, fertilisation rates<br>3. Total number of embryos, number and quality of embryos replaced and number of embryos frozen<br>4. Biochemical pregnancies, clinical pregnancies<br>5. Number of cycles abandoned for poor response and over response<br>6. Number of cases of ovarian hyperstimulation in each group
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath